CD44, an adhesion molecule implicated in tumor migration, progression, and metastasis, and CD133, a cell surface glycoprotein of uncertain function but identified in human solid tumors associated with aggressive behavior and metastasis, serve as markers for cancer stem cells (CSCs) [104]. The gene discussed is CD44; the disease is neoplasm.